Huahai Pharmaceutical (600521.SH): Cilostazol Sodium Injection Obtains Drug Registration Certificate

China Securities App News, Huahai Pharmaceutical (600521.SH) announced that the company recently received the "Drug Registration Certificate" for Carcasine Sodium Injection approved and issued by the National Medical Products Administration. Carcasine Sodium Injection is used for bleeding disorders of the urinary system, upper digestive tract, respiratory system, and gynecology, with significant efficacy in treating urinary system disorders. It can also be used for the prevention and treatment of surgical bleeding.